J. Niska

发表

Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer.

J. Cesaretti, D. Swartz, C. Vargas, 2019, Cancer treatment and research communications.

The Fibroblast Growth Factor–Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity

H. Cunliffe, N. Tran, A. Willis, 2008, Molecular Cancer Research.

Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality.

T. Sio, S. Schild, D. Jaroszewski, 2018, Journal of thoracic disease.

Tissue Expanders and Proton Beam Radiotherapy: What You Need to Know

M. Bues, R. Mahabir, C. Vargas, 2017, Plastic and reconstructive surgery. Global open.

Nurse and physician barriers to spiritual care provision at the end of life.

T. VanderWeele, C. Mitchell, A. Enzinger, 2014, Journal of pain and symptom management.

Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer

J. Sloan, A. Tan, M. Halyard, 2017, Quality of Life Research.

First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry

L. Mcgee, W. Hartsell, C. Vargas, 2018, Acta oncologica.

Therapeutic Intervention for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Systematic Review and Meta-Analysis

A. Fagin, A. Kuriyama, J. Jackson, 2012, PloS one.

Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose

S. Schild, M. Fatyga, M. Herman, 2021, Journal of Cancer Therapy.

Radiation and the heart: systematic review of dosimetry and cardiac endpoints

S. Schild, F. Mookadam, C. Vargas, 2018, Expert review of cardiovascular therapy.

Proton beam therapy reirradiation for breast cancer: Multi‐institutional prospective PCG registry analysis

H. Kosiorek, L. Mcgee, C. Rossi, 2019, The breast journal.

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy

J. Sloan, A. Dueck, A. Tan, 2020, Journal of Patient-Reported Outcomes.

Choosing wisely after publication of level I evidence in breast cancer radiotherapy

B. Pockaj, D. Northfelt, R. Gray, 2018, Breast cancer.

Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone

H. Kosiorek, L. Mcgee, C. Rossi, 2022, Frontiers in Oncology.

Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer

W. Hartsell, S. Keole, C. Vargas, 2018, Advances in radiation oncology.

Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.

A. Zhu, P. Hahn, T. Hong, 2016, Practical radiation oncology.

Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease

J. Jett, S. Schild, J. Niska, 2018, Clinical lung cancer.

Acute toxicities after proton beam therapy following breast‐conserving surgery for breast cancer: Multi‐institutional prospective PCG registry analysis

L. Mcgee, C. Rossi, L. Rosen, 2020, The breast journal.